SOA Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Sell
5,991
-1,481
-20% -$38.7K 0.02% 248
2026
Q1
$210K Buy
7,472
+1,074
+17% +$28.6K 0.04% 192
2025
Q4
$159K Sell
6,398
-638
-9% -$16.1K 0.03% 230
2025
Q3
$179K Sell
7,036
-808
-10% -$19.9K 0.03% 214
2025
Q2
$190K Sell
7,844
-372
-5% -$8.68K 0.04% 202
2025
Q1
$208K Sell
8,216
-1,121
-12% -$29.3K 0.04% 182
2024
Q4
$248K Sell
9,337
-726
-7% -$19.7K 0.05% 160
2024
Q3
$291K Buy
10,063
+160
+2% +$4.67K 0.06% 149
2024
Q2
$277K Sell
9,903
-5,260
-35% -$145K 0.06% 147
2024
Q1
$421K Buy
15,163
+1,595
+12% +$44.3K 0.09% 119
2023
Q4
$391K Sell
13,568
-4,833
-26% -$146K 0.09% 117
2023
Q3
$610K Sell
18,401
-259
-1% -$9.16K 0.15% 81
2023
Q2
$684K Sell
18,660
-626
-3% -$24.4K 0.16% 73
2023
Q1
$787K Buy
19,286
+4,396
+30% +$190K 0.19% 66
2022
Q4
$763K Sell
14,890
-273
-2% -$13.1K 0.21% 65
2022
Q3
$663K Buy
15,163
+230
+2% +$11.2K 0.2% 69
2022
Q2
$782K Sell
14,933
-190
-1% -$9.68K 0.23% 66
2022
Q1
$782K Buy
15,123
+496
+3% +$25.7K 0.19% 78
2021
Q4
$854K Buy
14,627
+70
+0.5% +$3.47K 0.21% 71
2021
Q3
$626K Buy
14,557
+2,024
+16% +$89.7K 0.16% 84
2021
Q2
$490K Sell
12,533
-1,776
-12% -$69.1K 0.13% 107
2021
Q1
$518K Buy
14,309
+37
+0.3% +$1.31K 0.14% 92
2020
Q4
$495K Buy
+14,272
New +$524K 0.13% 88

Other funds holding PFE

SOA Wealth Advisors's PFE Position: Q2 2026 in Review

SOA Wealth Advisors reduced its Pfizer (PFE) stake by 20% in Q2 2026, selling an estimated $38.7K and leaving 5,991 shares worth $144K. The position accounts for 0.02% of the portfolio, ranked #248.

SOA Wealth Advisors first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $854K in Q4 2021. 632 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SOA Wealth Advisors held 5,991 shares of Pfizer worth $144K as of Q2 2026.
  • SOA Wealth Advisors sold 1,481 Pfizer shares in Q2 2026, an estimated $38.7K.
  • Pfizer made up 0.02% of SOA Wealth Advisors's portfolio in Q2 2026, its #248 holding.
  • SOA Wealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • SOA Wealth Advisors's Pfizer position peaked at $854K in Q4 2021.
  • 632 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.